NRG-GI003 with Study PI, Dr. Hong
Dr. Ted Hong discusses the NRG-GI003 study comparing proton versus photons for hepatocellular carcinoma.
15 Jul 202522min
NRG-CC010 with Dr. Edward Tanner
NRG Oncology Podcast Co-hosts sit with Dr. Edward Tanner, the Principal Investigator of the NRG-CC010 trial assessing the impact of sentinel lymph node mapping on patient-reported lower extremity limb...
24 Jun 202519min
NRG-NSABP B-51/RTOG 1304 Results in NEJM
We discuss the results of NRG-NSABP B-51/RTOG 1304 in breast cancer, reported today in the New England Journal of Medicine.
5 Jun 202546min
The NRG-BR003 Results in Triple-Negative Breast Cancer
Our co-hosts discuss triple-negative breast cancer in light of the recently presented results at the 2025 ASCO Annual Meeting. We interview Dr. Vicente Valero, the NRG-BR003 PI, and Dr. Julie Gralow, ...
1 Jun 202532min
Patient Advocacy in Clinical Research and the Importance of the Patient-Physician Relationship
The NRG Oncology Podcast Co-hosts sit with NRG Oncology Patient Advocate, Tambre Leighn, to discuss what our patient advocates do in the process of our clinical trials from concept to reporting result...
20 Mai 202520min
NRG-CC009 for Brain Mets from SCLC with Dr. Vinai Gondi
NRG Oncology Podcast co-hosts talk with Dr. Vinai Gondi, the Principal Investigator of the NRG-CC009 phase III clinical study assessing stereotactic radiosurgery (SRS) versus hippocampal-avoidant whol...
2 Mai 202533min
NRG-RTOG 0848 Results in Pancreatic Cancer
Our co-hosts sit with Drs. Ross Abrams and Karyn Goodman to discuss the results of NRG-RTOG 0848 studying adjuvant chemotherapy with or without chemoradiation for patients with resected periampullary ...
25 Apr 202536min
An Interview with ASCO CEO, Dr. Hudis
The NRG Oncology Podcast Co-hosts interview Dr. Clifford Hudis - the CEO of the American Society of Clinical Oncology (ASCO) on how ASCO and the NCTN collaborate, the cost and complexity of conducting...
8 Apr 202531min
